Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
56 hedge funds and large institutions have $158M invested in Oxford Immunotec Global PLC Ordinary Shares in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 8 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 14
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
2% less funds holding
Funds holding: 57 → 56 (-1)
11% less capital invested
Capital invested by funds: $179M → $158M (-$20.4M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$5.41M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.51M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.07M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$848K |
| 5 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$640K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
-$7.16M |
| 2 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$5M |
| 3 |
O
OppenheimerFunds
New York
|
-$3.28M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$720K |
| 5 |
CC
Casdin Capital
New York
|
-$198K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
51
BlackRock Advisors
Wilmington,
Delaware
| $69K | -$52.7K | -5,381 | -41% |
|
52
BlackRock
New York
| $18K | -$10K | -1,021 | -33% |
|
53
Citigroup
New York
| $12K | -$125K | -12,771 | -91% |
|
54
BNP Paribas Financial Markets
Paris,
France
| $7.78K | +$8.46K | +864 | New |
|
55
Bank of America
Charlotte,
North Carolina
| $4K | +$4.1K | +419 | New |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| $1K | +$1.2K | +122 | New |
|
|
LPU
57
Lansdowne Partners (UK)
London,
United Kingdom
| – | -$7.16M | -722,354 | Closed |
|
|
TAM
58
Tiverton Asset Management
Wilimington,
Delaware
| – | -$5M | -504,000 | Closed |
|
|
CC
59
Casdin Capital
New York
| – | -$198K | -20,000 | Closed |
|
60
Goldman Sachs
New York
| – | -$131K | -13,244 | Closed |
|
|
BG
61
BlackRock Group
London,
United Kingdom
| – | -$26K | -2,643 | Closed |
|
62
Barclays
London,
United Kingdom
| – | -$8K | -900 | Closed |
|
63
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -73 | Closed |
|
|
PSC
64
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$1K | -65 | Closed |
|
OXFD Hedge Fund Activity: Q2 2016 in Review
56 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2016, worth a combined $158M — down 11% from $179M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of OXFD and 7 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 24 added.
The largest buyer was Redmile Group, adding an estimated $5.41M. The largest seller was Lansdowne Partners (UK), exiting entirely with an estimated $7.16M sold.
- 56 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2016, down from 57 in Q1 2016.
- Funds reported $158M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2016, down 11% quarter-over-quarter.
- 7 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2016 and 8 closed out, a net change of -1 holder.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2016 was Redmile Group, an estimated $5.41M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2016 was Lansdowne Partners (UK), an estimated $7.16M sold.
Based on aggregated 13F filings for Q2 2016.